Drug Detail

Information about PLX3397 + Pembrolizumab

Generic Name	PLX3397 + Pembrolizumab
IND
Brand Name (US)
Manufacturer	Plexxicon + Merck
Drug Type
Delivery	Oral (PLX3397) IV (Pembrolizumab)
Approval Status	One is approved, the other is not
Indications
Overall Strategy
Strategy
Drug Category	KIT/PDGFRA + PD-1 inhibitor

Links
Trials of this drug
	A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Trial results